Lates News

date
09/08/2025
A new study found that weight loss medications can significantly improve health conditions, although they also increase healthcare expenditures over time. Novo Nordisk's semaglutide, the active ingredient in Wegovy and Ozempic, significantly reduced weight, blood pressure, and cholesterol after two years. Excluding the monthly drug price of up to $1000, insurance companies increased healthcare costs by $67 per month for diabetic patients and $81 per month for non-diabetic patients.
Latest
See all latestmore